| Literature DB >> 26156325 |
Shuo Zeng1, Yu-Feng Xiao1, Bo Tang1, Chang-Jiang Hu1, Rei Xie1, Shi-Ming Yang1, Bo-Sheng Li2.
Abstract
Digestive tract cancers (DTCs) are a leading cause of cancer-related death worldwide. Current therapeutic tools for advanced stage DTCs have limitations, and patients with early stage DTCs frequently have a missed diagnosis due to shortage of efficient biomarkers. Consequently, it is necessary to develop novel biomarkers for early diagnosis and novel therapeutic targets for treatment of DTCs. In recent years, long noncoding RNAs (lncRNAs), a class of noncoding RNAs with >200 nucleotides, have been shown to be aberrantly expressed in DTCs and to have an important role in DTC development: the expression profiles of lncRNAs strongly correlated with poor survival of patients with DTCs, and lncRNAs acted as oncogenes or tumor suppressor genes in DTC progression. In this review, we summarized the functional lncRNAs and expounded on their regulatory mechanisms in DTCs. ©AlphaMed Press.Entities:
Keywords: Biomarker; Digestive tract cancers; Epigenetic regulation; Long noncoding RNAs
Mesh:
Substances:
Year: 2015 PMID: 26156325 PMCID: PMC4524753 DOI: 10.1634/theoncologist.2014-0475
Source DB: PubMed Journal: Oncologist ISSN: 1083-7159